The DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.
An overview of clinical and commercial impact of drug delivery systems
Open accessAbstract
Drug delivery systems are widely researched and developed to improve the delivery of pharmaceutical compounds and molecules. The last few decades have seen a marked growth of the field fueled by increased number of researchers, research funding, venture capital and the number of start-ups. Collectively, the growth has led to novel systems that make use of micro/nano-particles, transdermal patches, inhalers, drug reservoir implants and antibody-drug conjugates. While the increased research activity is clearly an indication of proliferation of the field, clinical and commercial translation of early-stage research ideas is critically important for future growth and interest in the field. Here, we will highlight some of the examples of novel drug delivery systems that have undergone such translation. Specifically, we will discuss the developments, advantages, limitations and lessons learned from: (i) microparticle-based depot formulations, (ii) nanoparticle-based cancer drugs, (iii) transdermal systems, (iv) oral drug delivery systems, (v) pulmonary drug delivery, (vi) implants and (vii) antibody-drug conjugates. These systems have impacted treatment of many prevalent diseases including diabetes, cancer and cardiovascular diseases, among others. At the same time, these systems are integral and enabling components of products that collectively generate annual revenues exceeding US $100 billion. These examples provide strong evidence of the clinical and commercial impact of drug delivery systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
Doxil® — The first FDA-approved nano-drug: Lessons learned
Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792
Cancer nanotechnology: opportunities and challenges
Ferrari, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1566 · Cited by 4,558
Drug Delivery Systems: Entering the Mainstream
Allen, T. M., & Cullis, P. R. (2004) · Science · doi:10.1126/science.1095833 · Cited by 4,552
Trastuzumab emtansine for HER2-positive advanced breast cancer
Verma, S., Miles, D., Gianni, L., Krop, I. E., Welslau, M., Baselga, J., Pegram, M., Oh, D.-Y., Diéras, V., Guardino, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1209124 · Cited by 3,834
Prausnitz, M. R., & Langer, R. (2008) · Nature Biotechnology · doi:10.1038/nbt.1504 · Cited by 3,517
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,515
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
Davis, M. E., Zuckerman, J. E., Choi, C. H. J., Seligson, D., Tolcher, A., Alabi, C. A., Yen, Y., Heidel, J. D., & Ribas, A. (2010) · Nature · doi:10.1038/nature08956 · Cited by 2,505
Gradishar, W. J., Tjulandin, S., Davidson, N., Shaw, H., Desai, N., Bhar, P., Hawkins, M., & O'Shaughnessy, J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.937 · Cited by 2,153
Microneedles for drug and vaccine delivery
Kim, Y.-C., Park, J.-H., & Prausnitz, M. R. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.04.005 · Cited by 1,760
Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers
Ensign, L. M., Cone, R., & Hanes, J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.12.009 · Cited by 1,623
Nanoparticle Delivery of Cancer Drugs
Wang, A. Z., Langer, R., & Farokhzad, O. C. (2012) · Annual Review of Medicine · doi:10.1146/annurev-med-040210-162544 · Cited by 1,561
Microneedles for transdermal drug delivery
Prausnitz, M. R. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.023 · Cited by 1,521
Gaudana, R., Ananthula, H. K., Parenky, A., & Mitra, A. K. (2010) · The AAPS Journal · doi:10.1208/s12248-010-9183-3 · Cited by 1,406
Gabizón, A., Catane, R., Uziely, B., Kaufman, B., Safra, T., Cohen, R., Martin, F., Huang, A., & Barenholz, Y. (1994) · PubMed · Cited by 1,382
Therapeutic antibodies: successes, limitations and hopes for the future
Chames, P., Van Regenmortel, M., Weiss, E., & Baty, D. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00190.x · Cited by 1,382
Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index
Junutula, J. R., Raab, H., Clark, S., Bhakta, S., Leipold, D. D., Weir, S., Chen, Y., Simpson, M., Tsai, S. P., Dennis, M. S., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt.1480 · Cited by 1,382
Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas
Younes, A., Bartlett, N. L., Leonard, J. P., Kennedy, D. A., Lynch, C. M., Sievers, E. L., & Forero-Torres, A. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002965 · Cited by 1,368
Inhaling medicines: delivering drugs to the body through the lungs
Patton, J. S., & Byron, P. R. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2153 · Cited by 1,331
Polymers for the sustained release of proteins and other macromolecules
LANGER, R., & FOLKMAN, J. (1976) · Nature · doi:10.1038/263797a0 · Cited by 1,182
Hrkach, J., Von Hoff, D., Ali, M. M., Andrianova, E., Auer, J., Campbell, T., De Witt, D., Figa, M., Figueiredo, M., Horhota, A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003651 · Cited by 1,147
Arming antibodies: prospects and challenges for immunoconjugates
Wu, A. M., & Senter, P. D. (2005) · Nature Biotechnology · doi:10.1038/nbt1141 · Cited by 1,052
Minimal "Self" Peptides That Inhibit Phagocytic Clearance and Enhance Delivery of Nanoparticles
Rodriguez, P. L., Harada, T., Christian, D. A., Pantano, D. A., Tsai, R. K., & Discher, D. E. (2013) · Science · doi:10.1126/science.1229568 · Cited by 985
Healing sound: the use of ultrasound in drug delivery and other therapeutic applications
Mitragotri, S. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1662 · Cited by 980
Self-citationHaran, G., Cohen, R., Bar, L. K., & Barenholz, Y. (1993) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(93)90105-9 · Cited by 934
A controlled-release microchip
Santini, J. T., Cima, M. J., & Langer, R. (1999) · Nature · doi:10.1038/16898 · Cited by 868
Kalia, Y. N., Naik, A., Garrison, J., & Guy, R. H. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.026 · Cited by 858
Direct Fabrication and Harvesting of Monodisperse, Shape-Specific Nanobiomaterials
Rolland, J. P., Maynor, B. W., Euliss, L. E., Exner, A. E., Denison, G. M., & DeSimone, J. M. (2005) · Journal of the American Chemical Society · doi:10.1021/ja051977c · Cited by 852
Biologically erodable microspheres as potential oral drug delivery systems
Mathiowitz, E., Jacob, J. S., Jong, Y. S., Carino, G. P., Chickering, D. E., Chaturvedi, P., Santos, C. A., Vijayaraghavan, K., Montgomery, S., Bassett, M., et al. (1997) · Nature · doi:10.1038/386410a0 · Cited by 823
Biodegradable microspheres for protein delivery
Sinha, V. R., & Trehan, A. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00194-9 · Cited by 814
Large unilamellar liposomes with low uptake into the reticuloendothelial system
Allen, T. M., & Chonn, A. (1987) · FEBS Letters · doi:10.1016/0014-5793(87)80506-9 · Cited by 729
Protein Instability in Poly(Lactic-co-Glycolic Acid) Microparticles
van de Weert, M., Hennink, W. E., & Jiskoot, W. (2000) · Pharmaceutical Research · doi:10.1023/a:1026498209874 · Cited by 708
Green, M. R., Manikhas, G. M., Orlov, S., Afanasyev, B., Makhson, A. M., Bhar, P., & Hawkins, M. J. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl104 · Cited by 667
Antibody–drug conjugates: targeted drug delivery for cancer
Alley, S. C., Okeley, N. M., & Senter, P. D. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2010.06.170 · Cited by 656
Dalby, B. (2004) · Methods · doi:10.1016/j.ymeth.2003.11.023 · Cited by 619
Stabilization of proteins encapsulated in injectable poly (lactide- co-glycolide)
Zhu, G., Mallery, S. R., & Schwendeman, S. P. (2000) · Nature Biotechnology · doi:10.1038/71916 · Cited by 609
Synthesis of site-specific antibody-drug conjugates using unnatural amino acids
Axup, J. Y., Bajjuri, K. M., Ritland, M., Hutchins, B. M., Kim, C. H., Kazane, S. A., Halder, R., Forsyth, J. S., Santidrian, A. F., Stafin, K., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1211023109 · Cited by 596
Non-invasive glucose monitoring technology in diabetes management: A review
Vashist, S. K. (2012) · Analytica Chimica Acta · doi:10.1016/j.aca.2012.03.043 · Cited by 575
Challenges for the oral delivery of macromolecules
Goldberg, M., & Gomez-Orellana, I. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1067 · Cited by 544
Is the oral route possible for peptide and protein drug delivery?
Morishita, M., & Peppas, N. A. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.08.005 · Cited by 515 · cited 1×
“The primary excitement in the field of oral delivery, however, has been improving the ability to deliver proteins and peptides [89].”
BackgroundAerosol drug delivery: developments in device design and clinical use
Dolovich, M. B., & Dhand, R. (2011) · The Lancet · doi:10.1016/s0140-6736(10)60926-9 · Cited by 505
Preclinical and clinical studies of anticancer agent‐incorporating polymer micelles
Matsumura, Y., & Kataoka, K. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01103.x · Cited by 501
Dry Powder Inhaler Formulation
Telko, M. J., & Hickey, A. J. (2005) · Respiratory Care · doi:10.4187/respcare.05501209 · Cited by 498
Ponchel, G. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00040-4 · Cited by 494
JIANG, W., GUPTA, R., DESHPANDE, M., & SCHWENDEMAN, S. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.09.003 · Cited by 478
Micro-scale devices for transdermal drug delivery
Arora, A., Prausnitz, M. R., & Mitragotri, S. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.08.032 · Cited by 464
Self-citationUltrasound-mediated transdermal drug delivery: Mechanisms, scope, and emerging trends
Polat, B. E., Hart, D., Langer, R., & Blankschtein, D. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.01.006 · Cited by 447
First-in-Human Testing of a Wirelessly Controlled Drug Delivery Microchip
Farra, R., Sheppard, N. F., McCabe, L., Neer, R. M., Anderson, J. M., Santini, J. T., Cima, M. J., & Langer, R. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003276 · Cited by 437
Nasal drug delivery: new developments and strategies
Illum, L. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02529-1 · Cited by 431
Peptides as Targeting Elements and Tissue Penetration Devices for Nanoparticles
Ruoslahti, E. (2012) · Advanced Materials · doi:10.1002/adma.201200454 · Cited by 419
The lung as a route for systemic delivery of therapeutic proteins and peptides
Uchenna Agu, R., Ikechukwu Ugwoke, M., Armand, M., Kinget, R., & Verbeke, N. (2001) · Respiratory Research · doi:10.1186/rr58 · Cited by 411
Transepithelial Transport of Fc-Targeted Nanoparticles by the Neonatal Fc Receptor for Oral Delivery
Pridgen, E. M., Alexis, F., Kuo, T. T., Levy-Nissenbaum, E., Karnik, R., Blumberg, R. S., Langer, R., & Farokhzad, O. C. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3007049 · Cited by 405
Problems With Inhaler Use: A Call for Improved Clinician and Patient Education
Fink, J. B., & Rubin, B. K. (2005) · Respiratory Care · doi:10.4187/respcare.05501360 · Cited by 358
Drug delivery for posterior segment eye disease.
Geroski, D. H., & Edelhauser, H. F. (2000) · PubMed · Cited by 342
Recent advances in pulmonary drug delivery using large, porous inhaled particles
Edwards, D. A., Ben-Jebria, A., & Langer, R. (1998) · Journal of Applied Physiology · doi:10.1152/jappl.1998.85.2.379 · Cited by 341
Application of Micro- and Nano-Electromechanical Devices to Drug Delivery
Staples, M., Daniel, K., Cima, M. J., & Langer, R. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9906-4 · Cited by 311
Bernkop-Schnürch, A. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00204-6 · Cited by 309
Maturing antibody–drug conjugate pipeline hits 30
Mullard, A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4009 · Cited by 295
A month–long effect from a single injection of microencapsulated human growth hormone
Johnson, O. L., Cleland, J. L., Lee, H. J., Charnis, M., Duenas, E., Jaworowicz, W., Shepard, D., Shahzamani, A., Jones, A. J. S., & Putney, S. D. (1996) · Nature Medicine · doi:10.1038/nm0796-795 · Cited by 292
Nyman, D. W., Campbell, K. J., Hersh, E., Long, K., Richardson, K., Trieu, V., Desai, N., Hawkins, M. J., & Von Hoff, D. D. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.6148 · Cited by 286
Treatment of Cytomegalovirus Retinitis with a Sustained-Release Ganciclovir Implant
Musch, D. C., Martin, D. F., Gordon, J. F., Davis, M. D., & Kuppermann, B. D. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707103370203 · Cited by 286
Discovery of transdermal penetration enhancers by high-throughput screening
Karande, P., Jain, A., & Mitragotri, S. (2004) · Nature Biotechnology · doi:10.1038/nbt928 · Cited by 280
Self-citationHollander, P. A., Blonde, L., Rowe, R., Mehta, A. E., Milburn, J. L., Hershon, K. S., Chiasson, J.-L., Levin, S. R., & for the Exubera Phase III Study Group (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2356 · Cited by 264
Reservoir-based drug delivery systems utilizing microtechnology
Stevenson, C. L., Santini, J. T., & Langer, R. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.02.005 · Cited by 250
Engineered antibody-drug conjugates with defined sites and stoichiometries of drug attachment
McDonagh, C. F., Turcott, E., Westendorf, L., Webster, J. B., Alley, S. C., Kim, K., Andreyka, J., Stone, I., Hamblett, K. J., Francisco, J. A., et al. (2006) · Protein Engineering Design and Selection · doi:10.1093/protein/gzl013 · Cited by 243
Gabizon, A. A., Barenholz, Y., & Bialer, M. (1993) · Pharmaceutical Research · doi:10.1023/a:1018907715905 · Cited by 237
Daddona, P. E., Matriano, J. A., Mandema, J., & Maa, Y.-F. (2011) · Pharmaceutical Research · doi:10.1007/s11095-010-0192-9 · Cited by 234
Sanborn, G. E. (1992) · Archives of Ophthalmology · doi:10.1001/archopht.1992.01080140044023 · Cited by 230
Enhancing paracellular permeability by modulating epithelial tight junctions
Ward, P. D., Tippin, T. K., & Thakker, D. R. (2000) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(00)00302-3 · Cited by 227
Zolot, R. S., Basu, S., & Million, R. P. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3980 · Cited by 227
Quattrin, T., Bélanger, A., Bohannon, N. J. V., Schwartz, S. L., & for the Exubera Phase III Study Group (2004) · Diabetes Care · doi:10.2337/diacare.27.11.2622 · Cited by 225
The history and development of the fentanyl series
Stanley, T. H. (1992) · Journal of Pain and Symptom Management · doi:10.1016/0885-3924(92)90047-l · Cited by 214
Kermode, M. (2004) · Health Promotion International · doi:10.1093/heapro/dah110 · Cited by 212
Minimally Invasive Insulin Delivery in Subjects with Type 1 Diabetes Using Hollow Microneedles
Gupta, J., Felner, E. I., & Prausnitz, M. R. (2009) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2008.0103 · Cited by 209
Patton, J. S., Bukar, J., & Nagarajan, S. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00074-x · Cited by 193
Antibody–drug conjugates for cancer: poised to deliver?
Hughes, B. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3270 · Cited by 188
Clinical Developments in Nanotechnology for Cancer Therapy
Heidel, J. D., & Davis, M. E. (2011) · Pharmaceutical Research · doi:10.1007/s11095-010-0178-7 · Cited by 170
Long Acting Injections and Implants
Wright, J. C., & Burgess, D. J. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0554-2 · Cited by 164
Black, C., Cummins, E., Royle, P., Philip, S., & Waugh, N. R. (2007) · Health Technology Assessment · doi:10.3310/hta11330 · Cited by 159
Intravitreal Sustained-Release Ganciclovir
Smith, T. J. (1992) · Archives of Ophthalmology · doi:10.1001/archopht.1992.01080140111037 · Cited by 157
Preclinical to clinical development of the novel camptothecin nanopharmaceutical CRLX101
Svenson, S., Wolfgang, M., Hwang, J., Ryan, J. L., & Eliasof, S. D. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.03.007 · Cited by 153
Drug‐conjugated antibodies for the treatment of cancer
Lambert, J. M. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12044 · Cited by 148
Iontophoretic delivery of peptide drugs
Green, P. G. (1996) · Journal of Controlled Release · doi:10.1016/0168-3659(96)01354-5 · Cited by 148
Eliasof, S. D., Lazarus, D. D., Peters, C. G., Case, R. I., Cole, R. O., Hwang, J., Schluep, T., Chao, J., Lin, J. L., Yen, Y., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1309566110 · Cited by 147
Norman, J. J., Brown, M. R., Raviele, N., Prausnitz, M. R., & Felner, E. I. (2013) · Pediatric Diabetes · doi:10.1111/pedi.12031 · Cited by 145
Horowitz, A. T., Barenholz, Y., & Gabizón, A. (1992) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(92)90084-y · Cited by 140
Torres‐Lugo, M., García-Fuentes, M., Record, R. D., & Peppas, N. A. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00027-5 · Cited by 138
Microsystem technologies for implantable applications
Receveur, R. A. M., Lindemans, F. W., & de Rooij, N. F. (2007) · Journal of Micromechanics and Microengineering · doi:10.1088/0960-1317/17/5/r02 · Cited by 138
Oral delivery of macromolecules using intestinal patches: applications for insulin delivery
Whitehead, K. A., Shen, Z., & Mitragotri, S. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.04.013 · Cited by 129
Self-citationDevelopment and Scale-up of a Microsphere Protein Delivery System
Tracy, M. A. (1998) · Biotechnology Progress · doi:10.1021/bp9701271 · Cited by 124
History of Aerosol Therapy: Liquid Nebulization to MDIs to DPIs
ANDERSON, P. J. (2005) · Respiratory Care · doi:10.4187/respcare.05501139 · Cited by 120
Gupta, J., Felner, E. I., & Prausnitz, M. R. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0204 · Cited by 118
Electronic MEMS for triggered delivery
Grayson, A. R. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.07.012 · Cited by 115
Morton, S. W., Herlihy, K. P., Shopsowitz, K. E., Deng, Z. J., Chu, K. S., Bowerman, C. J., DeSimone, J. M., & Hammond, P. T. (2013) · Advanced Materials · doi:10.1002/adma.201302025 · Cited by 108
Pakalapati, L. V. V. (2003) · DSpace@MIT (Massachusetts Institute of Technology) · Cited by 99
Castelli, M., Friedman, K., Sherry, J. H., Brazzillo, K., Genoble, L., Bhargava, P., & Riley, M. G. I. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.03.003 · Cited by 97
Eldor, R., Arbit, E., Corcos, A., & Kidron, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059524 · Cited by 94
Recent Advances in Intestinal Macromolecular Drug Delivery via Receptor-Mediated Transport Pathways
Swaan, P. W. (1998) · Pharmaceutical Research · doi:10.1023/a:1011908128045 · Cited by 91
Mucoadhesive intestinal devices for oral delivery of salmon calcitonin
Gupta, V., Hwang, B. H., Lee, J. H., Anselmo, A. C., Doshi, N., & Mitragotri, S. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.09.004 · Cited by 89
Self-citationKarande, P., Jain, A., & Mitragotri, S. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.07.001 · Cited by 85
Self-citationJordan, F., Naylor, A., Kelly, C. A., Howdle, S. M., Lewis, A., & Illum, L. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.09.013 · Cited by 84
Cerebral edema associated with Gliadel wafers: Two case studies
Weber, E. L., & Goebel, E. A. (2005) · Neuro-Oncology · doi:10.1215/s1152851704000614 · Cited by 84
Zempsky, W. T., Sullivan, J. E., Paulson, D. M., & Hoath, S. B. (2004) · Clinical Therapeutics · doi:10.1016/s0149-2918(04)90183-x · Cited by 81
Torres‐Lugo, M., García-Fuentes, M., Record, R. D., & Peppas, N. A. (2002) · Biotechnology Progress · doi:10.1021/bp0101379 · Cited by 81
Rapid Local Anesthesia in Humans Using Minimally Invasive Microneedles
Gupta, J., Denson, D. D., Felner, E. I., & Prausnitz, M. R. (2011) · Clinical Journal of Pain · doi:10.1097/ajp.0b013e318225dbe9 · Cited by 72
The pharmaceutics and delivery of therapeutic polypeptides and proteins
Talmadge, J. E. (1993) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(93)90049-a · Cited by 69
Gastrointestinal Safety of an Extended-Release, Nondeformable, Oral Dosage Form (OROS??)*
Bass, D. M., Prevo, M. E., & Waxman, D. S. (2002) · Drug Safety · doi:10.2165/00002018-200225140-00004 · Cited by 67
New developments in sustained release drug delivery for the treatment of intraocular disease
Velez, G., & Whitcup, S. M. (1999) · British Journal of Ophthalmology · doi:10.1136/bjo.83.11.1225 · Cited by 65
Iontophoretic delivery of for postoperative analgesia
Ashburn, M. A., Stephen, R. L., Ackerman, E. W., Petelenz, T. J., Hare, B. D., Pace, N. L., & Hofman, A. A. (1992) · Journal of Pain and Symptom Management · doi:10.1016/0885-3924(92)90104-p · Cited by 58
Iontophoretic delivery of apomorphine:
Junginger, H. E. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00119-9 · Cited by 41
Chuang, H., Trieu, M., Hurley, J., Taylor, E. J., England, M. R., & Nasraway, S. A. (2008) · Journal of Diabetes Science and Technology · doi:10.1177/193229680800200410 · Cited by 33
Historical Overview of Long Acting Injections and Implants
Wright, J. C., & Hoffman, A. S. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0554-2_2 · Cited by 31
A commentary on transdermal drug delivery systems in clinical trials
Watkinson, A. C. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23490 · Cited by 25
Controlled release of a therapeutic protein
Langer, R. (1996) · Nature Medicine · doi:10.1038/nm0796-742 · Cited by 24
A personal account of translating discoveries in an academic lab
Langer, R. (2013) · Nature Biotechnology · doi:10.1038/nbt.2609 · Cited by 14
Cited by
Anselmo, A. C., & Mitragotri, S. (2016) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10003 · Cited by 1,321
Self-citationAlkilani, A., McCrudden, M. T., & Donnelly, R. (2015) · Pharmaceutics · doi:10.3390/pharmaceutics7040438 · Cited by 1,147
Emerging Frontiers in Drug Delivery
Tibbitt, M. W., Dahlman, J. E., & Langer, R. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.5b09974 · Cited by 975
Advances in Biomaterials for Drug Delivery
Fenton, O. S., Olafson, K. N., Pillai, P. S., Mitchell, M. J., & Langer, R. (2018) · Advanced Materials · doi:10.1002/adma.201705328 · Cited by 855
Polymer-Based Hydrogels Applied in Drug Delivery: An Overview
Thang, N. H., Chien, T. B., & Cuong, D. X. (2023) · Gels · doi:10.3390/gels9070523 · Cited by 812
Metadata
- Authors
- Anselmo, A. C., & Mitragotri, S.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2014-09
- Volume
- 190
- Pages
- 15-28
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2046627126
- Cited by
- 520
- References
- 117
- FWCI
- 19.76
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.